Half Year 2024 Molecular Partners AG Earnings Call Transcript
Good day and welcome to the Molecular Partners first half 2024 results conference call. (Operator Instructions) Please note today's event is being recorded. I'd now like to turn the conference over to Seth Lewis, Senior Vice President, Investor Relations. Please go ahead.
Thanks, Rocco. Good morning and good afternoon, everyone. Welcome to the Molecular Partners first half 2024 results call. My name is Seth Lewis, Senior Vice President of Investor Relations, and I'm joined this morning by Patrick Amstutz, CEO; Philippe Legenne, Chief Medical Officer; Daniel Steiner, Senior Vice President, Research and Technology; and Robert Hendriks, Senior Vice President of Finance.
Management will take a few minutes to make brief remarks, and then we will open up for question and answer period. If you have not had a chance to review the H1 press release, please feel free to do so on our website,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |